Share-Based Expense |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Expense |
Total share-based expense related to stock options and restricted stock units (“RSUs”) was approximately $ during each of the three months ended March 31, 2024 and 2023.
Share-based expense is classified in the condensed consolidated statements of operations as follows:
Employee Stock Options
stock option awards to purchase shares of common stock were granted during the three months ended March 31, 2024 and 2023. The Company recognized a total of approximately $ of share-based expense related to employee stock options during each of the three months ended March 31, 2024 and 2023. employee stock options or RSUs were exercised and expired during the three months ended March 31, 2024 and 2023.
Non-Employee Stock Options
There were non-employee stock options granted or exercised during the three months ended March 31, 2024 and 2023. non-employee stock option grants expired during the three months ended March 31, 2024. During the three months ended March 31, 2023, non-employee stock option grants to purchase approximately shares of common stock expired. The Company did t recognize any share-based expense related to non-employee stock options during the three months ended March 31, 2024 and 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||